FindTrial
Sign In

A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma

A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042432
Enrollment
Unknown
Registered
2021-01-21
Start date
2021-01-25
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal carcinoma

Interventions

Low, medium and high risk groups:Nil

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with mNPC who received platinum-based chemotherapy as the first-line treatment at Sun Yat-Sen University Cancer Center (SYSUCC) between January 2008 and December 2015 were initially evaluated for inclusion.

Exclusion criteria

Exclusion criteria: We excluded those with (i) uncertain TNM classifications, (ii) previous anticancer treatment, (iii) unconfirmed histology, (iv) cycles of first-line chemotherapy less than two, (v) previous or synchronous malignant tumors, and (vi) missing or unmeasurable radiological evaluation data.

Design outcomes

Primary

MeasureTime frame
PFS;OS;—

Countries

China

Contacts

Public ContactYan-Qun Xiang

Sun Yat-Sen University Cancer Center

xiangyq@sysucc.org.cn+86 18666096623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026